Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation

Liposomal paclitaxel formulations

(2012) Štěpán Koudelka et al.   JOURNAL OF CONTROLLED RELEASE

Advances of Paclitaxel Formulations Based on Nanosystem Delivery Technology

(2012) C. Luo et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future?

(2011) J. T. Ribeiro et al.   ANNALS OF ONCOLOGY

Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis

(2011) U. Fasol et al.   ANNALS OF ONCOLOGY

Formulation, Characterization and Hypersensitivity Evaluation of an Intravenous Emulsion Loaded with a Paclitaxel–Cholesterol Complex

(2011) Xue-Jun Xia et al.   CHEMICAL & PHARMACEUTICAL BULLETIN

Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20

(2011) Zsóka Weiszhár et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Impact of albumin on drug delivery — New applications on the horizon

(2011) Bakheet Elsadek et al.   JOURNAL OF CONTROLLED RELEASE

Lipid formulations of amphotericin B as first-line treatment of zygomycosis

(2009) G.L. Petrikkos   CLINICAL MICROBIOLOGY AND INFECTION

Lx2-32c, a novel taxane and its antitumor activities in vitro and in vivo

(2008) Hongbo Wang et al.   CANCER LETTERS

New taxanes in development

(2008) Cristiano Ferlini et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS